Home Pfizer and BioNTech to submit emergency use authorization request to FDA for COVID-19 vaccine
FXStreet News

Pfizer and BioNTech to submit emergency use authorization request to FDA for COVID-19 vaccine

Pfizer and BioNTech announced on Friday that they will be submitting an emergency use authorization request to the US Food and Drug Administration (FDA) on Friday.

Additional details of the announcement revealed that companies will be ready to distribute the vaccine within hours after the authorization. 

“To date, Data Monitoring Committee (DMC) for the study has not reported any serious safety concerns related to the vaccine,” Pfizer and BioNTech reiterated.

Market reaction

The S&P 500 Futures erased daily losses and turned flat at 3,578 ahead of the opening bell.

FX Street

FX Street

FXStreet is the leading independent portal dedicated to the Foreign Exchange (Forex) market. It was launched in 2000 and the portal has always been proud of their unyielding commitment to provide objective and unbiased information, to enable their users to take better and more confident decisions.